Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Moderna,
Levi & Korsinsky Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 – MRNA
06:30pm, Wednesday, 18'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 18, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna Lawsuit – MRNA
06:00pm, Wednesday, 18'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 18, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join – Contact The Gross Law Firm
01:22pm, Wednesday, 18'th Sep 2024
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Moderna, Inc. (NASDAQ: MRNA).
NEW YORK, NY / ACCESSWIRE / September 18, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
The Schall Law Firm Wants Investors To Participate In A Securities Fraud Case Against Moderna, Inc.
11:00am, Wednesday, 18'th Sep 2024
LAKE LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna
NTx Services Launches to Supercharge Next Generation mRNA Research
09:00am, Wednesday, 18'th Sep 2024
RIO RANCHO, N.M.--(BUSINESS WIRE)--NTx's new services offering provides faster and more affordable high-integrity, complex mRNA production powered by NTxscribe®.
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
09:00am, Wednesday, 18'th Sep 2024
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology compan
Moderna, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
07:15am, Wednesday, 18'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 18, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK CITY, NY / ACCESSWIRE / September 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Modern
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
05:49am, Wednesday, 18'th Sep 2024
Moderna hopes to win approvals for 10 programs by 2027. Vertex Pharmaceuticals could have multiple new blockbuster drugs on the market over the next few years.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna, Inc. Lawsuit - MRNA
09:30pm, Tuesday, 17'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
04:45pm, Tuesday, 17'th Sep 2024
Moderna (MRNA) shares surged Tuesday after Canadian regulators approved the biotech firm's updated COVID-19 vaccine.
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June
